220 related articles for article (PubMed ID: 27449035)
1. The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.
Ping JG; Wang F; Pu JX; Hou PF; Chen YS; Bai J; Zheng JN
Tumour Biol; 2016 Sep; 37(9):12823-12831. PubMed ID: 27449035
[TBL] [Abstract][Full Text] [Related]
2. Cullin1 is a novel marker of poor prognosis and a potential therapeutic target in human breast cancer.
Bai J; Yong HM; Chen FF; Mei PJ; Liu H; Li C; Pan ZQ; Wu YP; Zheng JN
Ann Oncol; 2013 Aug; 24(8):2016-22. PubMed ID: 23592700
[TBL] [Abstract][Full Text] [Related]
3. Cullin1 regulates proliferation, migration and invasion of glioma cells.
Fan YC; Zhu YS; Mei PJ; Sun SG; Zhang H; Chen HF; Chen C; Miao FA
Med Oncol; 2014 Oct; 31(10):227. PubMed ID: 25201578
[TBL] [Abstract][Full Text] [Related]
4. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
[TBL] [Abstract][Full Text] [Related]
5. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J
Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851
[TBL] [Abstract][Full Text] [Related]
6. [Effects of Cullin1 on the Biological Characteristics of Lung Adenocarcinoma
A549 and H1395 Cells].
Liu J; Su S; He H; Wang H; Zhang D
Zhongguo Fei Ai Za Zhi; 2021 Feb; 24(2):69-77. PubMed ID: 33478195
[TBL] [Abstract][Full Text] [Related]
7. Increased Cul1 expression promotes melanoma cell proliferation through regulating p27 expression.
Chen G; Li G
Int J Oncol; 2010 Nov; 37(5):1339-44. PubMed ID: 20878082
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G
Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721
[TBL] [Abstract][Full Text] [Related]
9. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
Li CY; Yao AM; Chang XN; Guo YH; Xu R
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
Chen Y; Sun Y; Rao Q; Xu H; Li L; Chang C
Oncotarget; 2015 Oct; 6(31):31203-15. PubMed ID: 26304926
[TBL] [Abstract][Full Text] [Related]
11. Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.
Chen YS; Meng F; Li HL; Liu QH; Hou PF; Bai J; Zheng JN
Oncotarget; 2016 Dec; 7(51):84299-84313. PubMed ID: 27732931
[TBL] [Abstract][Full Text] [Related]
12. CUL4B promotes aggressive phenotypes of renal cell carcinoma via upregulating c-Met expression.
Chen S; Wang Y; Chen L; Xia Y; Cui J; Wang W; Jiang X; Wang J; Zhu Y; Sun S; Zou Y; Gong Y; Shi B
Int J Biochem Cell Biol; 2021 Jan; 130():105887. PubMed ID: 33227394
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of LDHA Deliver Potential Anticancer Performance in Renal Cell Carcinoma.
Wang X; Xu L; Wu Q; Liu M; Tang F; Cai Y; Fan W; Huang H; Gu X
Urol Int; 2017; 99(2):237-244. PubMed ID: 27027898
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
J Cancer Res Clin Oncol; 2018 Jan; 144(1):39-52. PubMed ID: 28993942
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma.
Chen T; Liu L; Zou Y; Hu X; Zhang W; Zhou T; Luo X; Fu W; Xu J
Cancer Biol Med; 2021 Feb; 18(1):227-244. PubMed ID: 33628597
[TBL] [Abstract][Full Text] [Related]
18. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
[TBL] [Abstract][Full Text] [Related]
19. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
20. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
